STOCKHOLM, July 31, 2025 /PRNewswire/ -- BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai presented the latest findings on lecanemab (Leqembi®) at the Alzheimer's Association International Conference (AAIC), held in Toronto, July 27 to 31. The presentations included...
Hence then, the article about bioartic latest data presented at aaic 2025 reinforces lecanemab s clinical effect with consistent safety profile was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( BioArtic: Latest data presented at AAIC 2025 reinforces lecanemab's clinical effect with consistent safety profile )
Also on site :
- Gold Star Distribution Inc., Issues Recall of Certain FDA-Regulated Products in Three States Including Drugs, Devices, Cosmetics, Human Foods, and Pet Foods
- ’Beverly Hills, 90210’s Jason Priestley Shares Bold Callout After ‘Worst’ Travel Experience
- Tyler Perry Sued for Sexual Assault By New Accuser, an Actor in a ‘Madea’ Movie